# David Isenberg

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/david-isenberg/

## Facts

| Field | Value |
| --- | --- |
| Citations | 88,941 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 135 |
| i10-index | 874 |
| Last Known Institution | Regenerative Medicine Institute |
| OpenAlex ID | https://openalex.org/A5065798696 |
| ORCID iD | 0000-0001-9514-2455 |
| Works | 1,807 |

## Researcher papers

Showing 12 of 42.

- [Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus](https://scholariq.org/papers/derivation-and-validation-of-the-systemic-lupus-international-collaborating/)
- [The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosus](https://scholariq.org/papers/the-development-and-initial-validation-of-the-systemic-lupus-international/)
- [Systemic Lupus Erythematosus](https://scholariq.org/papers/systemic-lupus-erythematosus-6/)
- [CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients](https://scholariq.org/papers/cd19-cd24hicd38hi-b-cells-exhibit-regulatory-capacity-in-healthy-individuals-but/)
- [Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European community](https://scholariq.org/papers/preliminary-criteria-for-the-classification-of-sjogren-s-syndrome-results-of-a/)
- [Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial](https://scholariq.org/papers/efficacy-and-safety-of-rituximab-in-moderately-to-severely-active-systemic-lupus/)
- [Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy](https://scholariq.org/papers/compromised-function-of-regulatory-t-cells-in-rheumatoid-arthritis-and-reversal/)
- [Mortality in systemic lupus erythematosus](https://scholariq.org/papers/mortality-in-systemic-lupus-erythematosus/)
- [Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis](https://scholariq.org/papers/mycophenolate-mofetil-versus-cyclophosphamide-for-induction-treatment-of-lupus/)
- [Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis](https://scholariq.org/papers/joint-european-league-against-rheumatism-and-european-renal-association-european/)
- [The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index in patients with Systemic Lupus Erythematosus](https://scholariq.org/papers/the-reliability-of-the-systemic-lupus-international-collaborating-clinics/)
- [EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics](https://scholariq.org/papers/eular-recommendations-for-the-management-of-systemic-lupus-erythematosus-report/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)

## Researcher university

- [Regenerative Medicine Institute](https://scholariq.org/institutions/regenerative-medicine-institute/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.